Serum lncRNA-ANRIL and SOX9 expression levels in glioma patients and their relationship with poor prognosis

BACKGROUND: lncRNA-CDKN2B antisense RNA 1 (ANRIL) and SRY-box transcription factor 9 (SOX9) has abnormal expression in many tumors including glioma, but the underlying molecular mechanism is unclear. This study set out to investigate the serum lncRNA-ANRIL and SOX9 levels in glioma patients and thei...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Youlu, Jing, Yuesong, Zhang, Yuxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461887/
https://www.ncbi.nlm.nih.gov/pubmed/34556140
http://dx.doi.org/10.1186/s12957-021-02392-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461887/
https://www.ncbi.nlm.nih.gov/pubmed/34556140
http://dx.doi.org/10.1186/s12957-021-02392-2

Ejemplares similares